The report finds that the combined impact of actual 2026 Medicare Part D negotiated drug prices and expected 2027 prices ...

The Office of the Commissioner for Entrance Examinations (CEE) Kerala, has invited applications for admission to the ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...

Q3 2025 Earnings Call Transcript November 4, 2025 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency –– ...

A drug addict who used a knife to hold up a pharmacy was acting out of desperation, with his offending described as a “cry for help”.

Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...

I took on an aggressive player, raced against the clock, and found some great loot to fund future trips Topside ...

Fortrea Holdings Inc. ( FTRE) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST ...

NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan ...

Investing.com -- Evoke Pharma (NASDAQ:EVOK) stock surged 134% following the announcement that the company has entered into a definitive agreement to be acquired by QOL Medical, a privately held ...